Harvard Bioscience Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$595.30 | Buy/Sell | $591.94 | 4.15% | 1 | $227.24B |
| DHR | Danaher | Outperform |
10
|
$265.80 | Buy/Sell | $260.33 | 2.49% | 4 | $196.87B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$236.30 | Buy/Sell | $284.47 | 17.44% | 8 | $68.29B |
| LONN | Lonza Group | Buy |
16
|
CHF529.20 | Buy/Sell | CHF516.89 | 13.38% | 8 | CHF38.16B |
| BIO | Bio-Rad Laboratories Inc | Outperform |
16
|
$293.85 | Buy/Sell | $536.80 | 40.89% | 1 | $7.92B |
| MXCT | MaxCyte | Buy |
8
|
£3.75 | Buy/Sell | £9.66 | 83.20% | 6 | £303.18M |